Quince Therapeutics, Inc. is a biopharmaceutical company headquartered in South San Francisco, California, dedicated to developing innovative precision therapies aimed at treating rare and debilitating diseases. Leveraging cutting-edge research and advanced therapeutic platforms, Quince is committed to transforming the treatment landscape for patients with unmet medical needs. The company's portfolio includes targeted treatments designed to improve patient outcomes and quality of life, positioning it as a leader in the biopharmaceutical sector. With a strong pipeline and a focus on scientific excellence, Quince Therapeutics is well-poised for growth and impactful contributions to healthcare.